Hightide Therapeutics Raises $107 Million In Series C/C+ Financing To Advance Innovative Pipeline And Business Collaborations
Amount Raised
$107 Million
Round Type
Series C
Investors
Description
HighTide Therapeutics Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the closing of a $107 million Series C/C+ financing led by the TCM Healthcare Fund of Guangdong, managed by China Development Bank Capital. Other investors included Yuexiu Fund and Yuthai Fund.
Quick answer
HighTide Therapeutics raised $107 Million in a Series C round, dated January 5, 2023. Investors: Yuthai Fund, China Development Bank Capital and Tcm Healthcare Fund Of Guangdong.
- How much did HighTide Therapeutics raise?
- HighTide Therapeutics raised $107 Million in a Series C round on January 5, 2023.
- Who invested in HighTide Therapeutics?
- Yuthai Fund, China Development Bank Capital and Tcm Healthcare Fund Of Guangdong are named as investors in this round.
- What does HighTide Therapeutics do?
- HighTide is a globally integrated clinical-stage biopharmaceutical company focusing on the discovery and development of novel multifunctional therapies for metabolic and digestive diseases with significant unmet medical..
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as HighTide Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Disc raised $63M (Funding Round) on February 14, 2023.
- Provention Bio raised $35M on February 13, 2023.
- CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Pathos AI raised $20M on February 17, 2023.
Who to call at HighTide Therapeutics, and when
A new round usually means HighTide Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day HighTide Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HighTide Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HighTide Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HighTide Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HighTide Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.